Literature DB >> 10598806

Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1.

B Zhang1, A Henney, P Eriksson, A Hamsten, H Watkins, S Ye.   

Abstract

Allelic association methods are better suited than linkage analysis for mapping of susceptibility genes that confer modest increases in risk in complex diseases. In both family- and population-based association studies, it is very useful to have prior knowledge of all sequence variants and the degree of linkage disequilibrium in a candidate gene region. In this study, we scanned sequence variants in a 2.2-kb promoter sequence and all 13 exons (totalling 3.3 kb) of the matrix metalloproteinase-9 gene, which is associated with coronary heart disease and a candidate for other diseases involving connective tissue remodelling, such as cancer metastasis. The sequences had a total of ten variable sites, four in the promoter, five in the coding region (three of which alter the amino acid encoded) and one in the 3' untranslated sequence. Sequence inspection suggests that some of the variants will have a functional impact on either level of expression or enzymatic activity. Tight linkage disequilibrium was detected between variants across the entire length of the gene (approximately 9 kb), and frequencies of different haplotypes were determined. The data provide an essential tool for studies of the possible contribution of genetic variation at the matrix metalloproteinase-9 locus to genetically determined susceptibility to a number of important diseases. The results also provide experimental data on the extent of linkage disequilibrium in the general population, which is yet to be resolved.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598806     DOI: 10.1007/s004390051124

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  47 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  Association between matrix metalloproteinase gene polymorphisms and development of ischemic stroke.

Authors:  Yunhua Hao; Shihong Tian; Min Sun; Yuanjian Zhu; Zhiyu Nie; Shujuan Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Matrix metalloproteinase 9 gene polymorphisms are associated with a multiple family history of gastric cancer.

Authors:  Rieko Okada; Mariko Naito; Yuta Hattori; Toshio Seiki; Kenji Wakai; Hinako Nanri; Miki Watanabe; Sadao Suzuki; Tara Sefanya Kairupan; Naoyuki Takashima; Haruo Mikami; Keizo Ohnaka; Yoshiyuki Watanabe; Sakurako Katsuura-Kamano; Michiaki Kubo; Nobuyuki Hamajima; Hideo Tanaka
Journal:  Gastric Cancer       Date:  2016-04-06       Impact factor: 7.370

4.  Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: A systematic review and meta-analysis.

Authors:  Lingli Xin; Qingxiang Hou; Q I Xiong; Xiaoping Ding
Journal:  Biomed Rep       Date:  2015-04-06

5.  The association between genetic polymorphisms in matrix metalloproteinases and caries experience.

Authors:  Funda Çağırır Dindaroğlu; Nesrin Eronat; Asude Durmaz; Dilşah Çoğulu; Burak Durmaz; Özgür Çoğulu
Journal:  Clin Oral Investig       Date:  2021-02-27       Impact factor: 3.573

6.  A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women.

Authors:  F Lose; P J Thompson; D Duffy; G A Stewart; M-A Kedda
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

7.  Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.

Authors:  Rebecca Brooks; Nora Kizer; Loan Nguyen; Atthapon Jaishuen; Karolyn Wanat; Elizabeth Nugent; Perry Grigsby; Jenifer E Allsworth; Janet S Rader
Journal:  Gynecol Oncol       Date:  2009-11-10       Impact factor: 5.482

8.  MMP-9 gene variants increase the risk for non-atopic asthma in children.

Authors:  Leonardo A Pinto; Martin Depner; Norman Klopp; Thomas Illig; Christian Vogelberg; Erika von Mutius; Michael Kabesch
Journal:  Respir Res       Date:  2010-02-24

9.  Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease.

Authors:  Jeong-Ah Park; Kyung-Sue Shin; Youn Woo Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

10.  Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.

Authors:  Janusz K Rybakowski
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.